TY - JOUR
T1 - Characteristics and potential quality indicators for evaluating pre-travel consultations in Japan hospitals
T2 - the Japan Pretravel consultation registry (J-PRECOR)
AU - Yamamoto, Kei
AU - Asai, Yusuke
AU - Nakatani, Issaku
AU - Hayashi, Kenichi
AU - Nakagawa, Hidenori
AU - Shinohara, Koh
AU - Kanai, Shinichiro
AU - Shimatani, Michitsugu
AU - Yamato, Masaya
AU - Shimono, Nobuyuki
AU - Kitaura, Tsuyoshi
AU - Komiya, Nobuhiro
AU - Nagasaka, Atsushi
AU - Mikawa, Takahiro
AU - Manabe, Akihiro
AU - Matono, Takashi
AU - Yamamoto, Yoshihiro
AU - Ogawa, Taku
AU - Kutsuna, Satoshi
AU - Ohmagari, Norio
N1 - Funding Information:
This work was supported by grants from the National Center for Global Health and Medicine [29–1018].
Funding Information:
K.Y. has received research grants from Fujirebio, Inc., Mizuho Medy, Co., Ltd., and VisGene Inc., outside the submitted work. N.O. has received grants from Sanofi Pasteur and Eiken Chemical Co., Ltd., outside the submitted work. All remaining authors have declared no conflicts of interest.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Background: Awareness of pre-travel consultations (PTCs) and prevention methods for overseas travel-related diseases, and the understanding of PTCs among Japanese travelers and medical professionals remains low in Japan. A multicenter registry was established to examine PTCs in Japan. This study assessed the PTC implementation rate and examined the indicators of PTCs that can be used as criteria for evaluating quality. Methods: Clients who presented for their PTCs at 17 facilities and were registered between February 1, 2018, and May 31, 2020, were included. Medical information was extracted retrospectively via a web-based system. Correlations between vaccination risk categories and advice/intervention proportions by the facility were evaluated using Spearman’s ordered phase relations (α = 0.05). Results: Of the 9700 eligible clients (median age, 32 years; 880 [9.1%] aged < 16 years and 549 [5.7%] aged ≥65 years), the most common travel duration was ≥181 days (35.8%); higher among younger clients. The most common reason for travel was business (40.5%); the US (1118 [11.5%]) and Asia (4008 [41.3%]) were the most common destinations and continents, respectively. The vaccine number (median three per person) increased after the PTCs except for the tetanus toxoid. Only 60.8% of the clients recommended for malaria prophylaxis received anti-malarial agents. The gross national income; the incidence of human rabies, typhoid fever, falciparum malaria; and dengue risk category were associated with the percentage of hepatitis-A vaccines; explaining rabies post-exposure prophylaxis, typhoid-fever vaccinations, malaria-prophylaxis prescriptions; and mosquito repellants, respectively. Conclusions: Although the characteristics of the travelers differed, the quality of the PTCs should be improved to address, for example, the lower rate of acceptance of malaria prophylaxis in Japan.
AB - Background: Awareness of pre-travel consultations (PTCs) and prevention methods for overseas travel-related diseases, and the understanding of PTCs among Japanese travelers and medical professionals remains low in Japan. A multicenter registry was established to examine PTCs in Japan. This study assessed the PTC implementation rate and examined the indicators of PTCs that can be used as criteria for evaluating quality. Methods: Clients who presented for their PTCs at 17 facilities and were registered between February 1, 2018, and May 31, 2020, were included. Medical information was extracted retrospectively via a web-based system. Correlations between vaccination risk categories and advice/intervention proportions by the facility were evaluated using Spearman’s ordered phase relations (α = 0.05). Results: Of the 9700 eligible clients (median age, 32 years; 880 [9.1%] aged < 16 years and 549 [5.7%] aged ≥65 years), the most common travel duration was ≥181 days (35.8%); higher among younger clients. The most common reason for travel was business (40.5%); the US (1118 [11.5%]) and Asia (4008 [41.3%]) were the most common destinations and continents, respectively. The vaccine number (median three per person) increased after the PTCs except for the tetanus toxoid. Only 60.8% of the clients recommended for malaria prophylaxis received anti-malarial agents. The gross national income; the incidence of human rabies, typhoid fever, falciparum malaria; and dengue risk category were associated with the percentage of hepatitis-A vaccines; explaining rabies post-exposure prophylaxis, typhoid-fever vaccinations, malaria-prophylaxis prescriptions; and mosquito repellants, respectively. Conclusions: Although the characteristics of the travelers differed, the quality of the PTCs should be improved to address, for example, the lower rate of acceptance of malaria prophylaxis in Japan.
UR - http://www.scopus.com/inward/record.url?scp=85124029349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124029349&partnerID=8YFLogxK
U2 - 10.1186/s40794-021-00160-4
DO - 10.1186/s40794-021-00160-4
M3 - Article
AN - SCOPUS:85124029349
SN - 2055-0936
VL - 8
JO - Tropical Diseases, Travel Medicine and Vaccines
JF - Tropical Diseases, Travel Medicine and Vaccines
IS - 1
M1 - 6
ER -